Pharmafile Logo
Pharmafocus logo
Advanced Search
biogen_idec_hillerod_2008_11

FDA acting commissioner seeks review of controversial Alzheimer’s drug approval

July 12, 2021
Sales and Marketing

The FDA’s acting commissioner Janet Woodcock is asking for a federal investigation of doctors within her own agency who met …

News

New data demonstrates extensive activity of Shionogi’s antibiotic cefiderocol

July 12, 2021
Sales and Marketing

Shionogi’s novel antibiotic, cefiderocol, has extensive in vitro activity against some of the most difficult to treat carbapenem-resistant Gram-negative bacteria.The …

News

NICE rejects gene therapy for children with neurodegenerative disorder

July 9, 2021
Medical Communications

NICE does not recommend gene therapy OTL-200 (also called Libmeldy and made by Orchard Therapeutics) for treating children with the …

News

FDA narrows guidance on controversial Alzheimer’s drug

July 9, 2021
Medical Communications

A month after the approval of Biogen’s controversial new Alzheimer’s drug, Aduhelm, the FDA has narrowed its guidance on who …

News
biogen_austria_238

Global genetic exome sequence analysis collaboration announced

July 9, 2021
Medical Communications

AbbVie, Pfizer, and Biogen have announced the launch of the world’s largest browsable resource linking rare protein-coding genetic variants to …

News

Tech successful in harvesting cancer cells in brain metastases patients

July 9, 2021
Medical Communications

The University Medical Centre Hamburg-Eppendorf has published results of new work undertaken in patients with brain metastasis using ANGLE’s cell …

News

Children “extremely low risk” from COVID study finds

July 9, 2021
Medical Communications COVID-19, Vaccine

The overall risk of children becoming severely ill or dying from COVID-19 is extremely low, scientists from University College London, …

News

The pill to be sold over the counter for first time in UK history

July 8, 2021

The contraceptive pill will be sold over the counter without prescription for the first time in UK history. The MHRA …

News
andrei_r_-_shutterstock_1935537274_720

Exscientia receives $1.5 million Gates grant for Covid-19 therapy

July 8, 2021

The Oxford-based drugs firm Exscientia has won a $1.5 million grant from the Bill & Melinda Gates Foundation to create …

News
clip_image003

Gyros Protein Technologies and Cygnus Technologies expand collaboration

July 8, 2021

Gyros Protein has announced the next phase of its on-going collaboration with Cygnus Technologies alongside the introduction of a new …

News
laboratory-testing-az

New screening method set to speed up drug discovery in major diseases

July 8, 2021
drug discovery

Scientists from the University of Birmingham and the University of Leicester have discovered a new screening method that can test …

News
roche__tree

WHO recommends Roche and Sanofi treatments to cut COVID-19 death risk

July 8, 2021

The WHO has recommended using arthritis drugs Actemra from Roche and Kevzara from Sanofi with corticosteroids for COVID-19 patients. This …

News

Mass COVID testing reduces cases by a fifth study shows

July 7, 2021
Research and Development COVID-19 testing, COVID-19. testing, lateral flow tests, liverpool

A pilot study conducted by the University of Liverpool has found that mass rapid testing reduced COVID-19 cases in Liverpool …

News
subcutaneous-injection-tn

First ex vivo human skin platform investigating ISR launched

July 7, 2021
Research and Development

Genoskin has announced the launch of ISR Platform, a novel pre-clinical toolbox designed to study injection site reactions (ISR) in …

News

Summer COVID cases set to reach 2 million with 10 million isolating

July 7, 2021
Research and Development COVID-19, Lockdown, UK, Vaccine, government

Analysis from the Guardian has found that over two million people could contract COVID-19 this summer, which could therefore lead …

News
johnson_and_johnson_jj

EU orders nearly 40 million more J&J COVID vaccines

July 7, 2021
Research and Development

The EU has ordered nearly 40 million more doses of the J&J COVID-19 vaccines for European countries. This is despite …

News
boehringer_biberach_germany_copy

Breakthrough heart failure drug meets primary endpoint

July 7, 2021
Research and Development

The Phase III trial for empagliflozin, a treatment for patients with heart failure with preserved ejection fraction, has met its …

News
pfizer_building_logo2_1

Pfizer’s COVID-19 vaccine efficacy falls to 64% in Israel

July 6, 2021
Manufacturing and Production

Israel has reported a decrease to 64% in the effectiveness of the Pfizer-BioNTech COVID-19 vaccine in preventing infections and symptomatic …

News

UVC light found to inactivate COVID virus in study

July 6, 2021
Manufacturing and Production COVID-19, clinical trials, computer simulations, skin

A new study has found that Ultraviolet C (UVC) emitting lamps are fast, effective, and safe at inactivating SARS-CoV-2, the …

News
sos002

Sosei and InveniAI to collaborate on AI-powered drug discovery

July 6, 2021
Manufacturing and Production

Sosei Heptares and InveniAI have entered a multi-target AI-powered and GPCR-focused drug discovery collaboration. The two companies will combine InveniAI’s …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026